Evaxion A (EVAX) Common Equity (2019 - 2026)
Evaxion A's (EVAX) quarterly Common Equity came in at $13.2 million in Q1 2026, up 27.69% YoY from $10.3 million in Q1 2025, and down 22.49% on a QoQ basis from $17.0 million in Q4 2025.
Evaxion A (EVAX) Common Equity (2019 - 2026) Analysis & Trends
Evaxion A (EVAX) has 8 years of Common Equity data on file, last reported at $13.2 million in Q1 2026.
- Quarterly Common Equity rose 27.69% year-over-year to $13.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.2 million (up 27.69% YoY) and the FY2025 annual result came in at $17.0 million, up 1131.42% from the prior year.
- Common Equity eased to $13.2 million in Q1 2026, from $17.0 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $2.6 billion in Q1 2024 to a low of -$4.7 million in Q4 2023.
- A 5-year average of $169.6 million and a median of $7.4 million in 2022 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2023 — Common Equity sank 156.96% — and 2024, when it surged 39504.56%.
- Tracing EVAX's Common Equity over 5 years: stood at $8.3 million in 2022, then plunged by 156.96% to -$4.7 million in 2023, then soared by 65.07% to -$1.7 million in 2024, then surged by 1131.42% to $17.0 million in 2025, then fell by 22.49% to $13.2 million in 2026.
- The last three Common Equity figures came in at $13.2 million (Q1 2026), $17.0 million (Q4 2025), and $16.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 20.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 31.71 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 6.76 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 5.17 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.35 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 22.38 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 757.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 9.79 Bn |
| 10 | Evaxion A | 27.61 Mn | 27.61 Mn | - | 13.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.21 Mn |
| Dec 31, 2025 | 17.04 Mn |
| Sep 30, 2025 | 16.60 Mn |
| Jun 30, 2025 | 6.23 Mn |
| Mar 31, 2025 | 10.34 Mn |
| Dec 31, 2024 | -1.65 Mn |
| Jun 30, 2024 | 1.25 Mn |
| Mar 31, 2024 | 2.60 Bn |
| Dec 31, 2023 | -4.73 Mn |
| Sep 30, 2023 | -2.73 Mn |
| Jun 30, 2023 | 2.54 Mn |
| Mar 31, 2023 | 6.58 Mn |
| Dec 31, 2022 | 8.30 Mn |
| Sep 30, 2022 | 13.55 Mn |
| Jun 30, 2022 | 20.15 Mn |
| Mar 31, 2022 | 2.54 Mn |
| Dec 31, 2021 | 32.44 Mn |
| Sep 30, 2021 | 16.65 Mn |
| Jun 30, 2021 | 21.83 Mn |
| Mar 31, 2021 | 27.80 Mn |